Gopinathan Suma
SEC insider (Form 3/4/5 filer). CIK 0002071581. SVP, Discovery at LEXICON PHARMACEUTICALS, INC. (LXRX). 6 reported Form 4/5 transactions since Sep 2024; latest on Feb 28, 2026. Located in THE WOODLANDS, TX.
Companies Gopinathan Suma has filed insider reports for
- LEXICON PHARMACEUTICALS, INC. (LXRX): Officer, SVP, Discovery
Gopinathan Suma
CIK: 0002071581
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LEXICON PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Feb 28, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
ExerciseDirect14K shares- - Feb 28, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
ExerciseDirect20.3K shares- - Feb 28, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
ExerciseDirect65.6K shares- - Feb 28, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
Tax PaymentDirect24.3K shares at avg. $1.47$36K - Feb 12, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Units
238.5K shares- - Feb 12, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectStock Option (Right to Buy)
357.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 28, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Exercise | 14,000 | - | $0 | Direct |
| Feb 28, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Exercise | 20,310 | - | $0 | Direct |
| Feb 28, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Exercise | 65,640 | - | $0 | Direct |
| Feb 28, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Tax Payment | 24,338 | $1.47 | $35,777 | Direct |
| Feb 12, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Restricted Stock Units | 238,450 | - | - | Direct |
| Feb 12, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Stock Option (Right to Buy) | 357,680 | - | - | Direct |
1-6 of 6 transactions